Strides Pharma Science Reaches All-Time High, Receives 'Hold' Rating from MarketsMOJO

Strides Pharma Science, a midcap pharmaceutical company, has recently reached an all-time high in its stock price on October 17, 2024. The stock is currently trading at a price of Rs 1628.05, which is 1.42% away from its 52-week high of Rs 1651.15.

According to MarketsMOJO, a leading stock analysis platform, the stock has been given a 'Hold' rating. It has also been included in the Momentumnow Stocks list on MarketsMOJO since April 3, 2024.

In terms of performance, Strides Pharma is in line with the overall sector and has been gaining for the past 3 days, with a 4.44% increase in returns. The stock has been consistently trading at its current price since opening.

Moreover, Strides Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its stock price.

In comparison to the Sensex, Strides Pharma has shown a remarkable 1-year performance of 218.25%, while the Sensex has only seen a 22.87% increase.

Overall, Strides Pharma Science has been performing well in the midcap pharmaceutical industry and has shown significant growth in its stock price. Investors may want to keep an eye on this stock for potential future developments.